Risultati di ricerca - Portale di modelli di dati medici (MDM-Portal)

Filtra i risultati della ricerca
Seleziona modelli di dati

Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

1 Risultati di ricerca.

visit 2 (randomisation) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

- 08/08/17 - 1 modulo, 14 itemgroups, 17 elementi, 1 linguaggio

Itemgroups: administrative data, current tobacco use, baseline dyspnoea index, oropharyngeal candidasis examination, vital signs, pulmonary function testing, pulmonary funtion testing: FEV1, pulmonary function testing: FVC, pulmonary function testing: FEV1 /FVC ratio, St. George's respiratory questionnaire, EQ-5D, randomisation number, investigational product container number, transition dyspnoea index

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

Keywords

Sommario

Modelli di dati selezionati

visit 2 (randomisation) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

Keywords

Sommario

Modelli di dati selezionati

visit 2 (randomisation) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

Contatto

Aiuto